Ha ha yep....every time it's the same scenario.
Bought another parcel this morning $19.01 and sold it way too early at $19.51.
Just from the results presentation;
Really positive for TLX591 that pluvicto causes kidney damage to 40% of patients.
Not so good for those patients though...
Likely a problem for all PSMA targeting therapies.
TLX591 liver clearance a huge point of difference even at the same efficacy point.
Will be much more effective though.
Understanding Telix, page-1372
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.680(3.55%) |
Mkt cap ! $6.645B | |||
| Open | High | Low | Value | Volume |
| $18.93 | $19.86 | $18.75 | $46.49M | 2.405M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1753 | $19.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.86 | 1052 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |